BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37759102)

  • 61. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
    Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
    Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-6745-TIMP1 axis inhibits cell growth and metastasis in gastric cancer.
    Liu H; Xiang Y; Zong QB; Zhang XY; Wang ZW; Fang SQ; Zhang TC; Liao XH
    Aging (Albany NY); 2021 Nov; 13(21):24402-24416. PubMed ID: 34775375
    [TBL] [Abstract][Full Text] [Related]  

  • 63. TFF1 antagonizes TIMP-1 mediated proliferative functions in gastric cancer.
    Omar OM; Soutto M; Bhat NS; Bhat AA; Lu H; Chen Z; El-Rifai W
    Mol Carcinog; 2018 Nov; 57(11):1577-1587. PubMed ID: 30035371
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
    Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
    Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
    [TBL] [Abstract][Full Text] [Related]  

  • 65. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.
    Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M
    Cancer Gene Ther; 2004 Jan; 11(1):73-80. PubMed ID: 14681728
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma.
    Bernhard OK; Greening DW; Barnes TW; Ji H; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2372-9. PubMed ID: 23557862
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
    Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
    Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis
    Shou Y; Liu Y; Xu J; Liu J; Xu T; Tong J; Liu L; Hou Y; Liu D; Yang H; Cheng G; Zhang X
    Front Genet; 2022; 13():648134. PubMed ID: 35281807
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
    Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
    Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of Liuweibuqi capsule, a Chinese patent medicine, on the JAK1/STAT3 pathway and MMP9/TIMP1 in a chronic obstructive pulmonary disease rat model.
    Wang C; Li Z; Liu X; Peng Q; Li F; Li D; Wang C
    J Tradit Chin Med; 2015 Feb; 35(1):54-62. PubMed ID: 25842729
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    Huang R; Wang K; Gao L; Gao W
    Onco Targets Ther; 2019; 12():8895-8904. PubMed ID: 31802901
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma.
    Duch P; Díaz-Valdivia N; Ikemori R; Gabasa M; Radisky ES; Arshakyan M; Gea-Sorlí S; Mateu-Bosch A; Bragado P; Carrasco JL; Mori H; Ramírez J; Teixidó C; Reguart N; Fillat C; Radisky DC; Alcaraz J
    Matrix Biol; 2022 Aug; 111():207-225. PubMed ID: 35787446
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion.
    Tian Z; Ou G; Su M; Li R; Pan L; Lin X; Zou J; Chen S; Li Y; Huang K; Chen Y
    Cancer Lett; 2022 Oct; 546():215863. PubMed ID: 35961511
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
    Riccardo F; Arigoni M; Buson G; Zago E; Iezzi M; Longo D; Carrara M; Fiore A; Nuzzo S; Bicciato S; Nanni P; Landuzzi L; Cavallo F; Calogero R; Quaglino E
    BMC Genomics; 2014; 15 Suppl 3(Suppl 3):S1. PubMed ID: 25077564
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unraveling TIMP1: a multifaceted biomarker in colorectal cancer.
    Qiu X; Quan G; Ou W; Wang P; Huang X; Li X; Shen Y; Yang W; Wang J; Wu X
    Front Genet; 2023; 14():1265137. PubMed ID: 37842645
    [No Abstract]   [Full Text] [Related]  

  • 77. Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.
    Ishihara R; Oda T; Murakami Y; Matsumura I; Watanabe S; Asao Y; Masuda Y; Gotoh N; Kasamatsu T; Takei H; Kobayashi N; Sasaki N; Saitoh T; Murakami H; Handa H
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768545
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes.
    Lutz AM; Willmann JK; Cochran FV; Ray P; Gambhir SS
    PLoS Med; 2008 Aug; 5(8):e170. PubMed ID: 18715113
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proteomic patterns of tumour subsets in non-small-cell lung cancer.
    Yanagisawa K; Shyr Y; Xu BJ; Massion PP; Larsen PH; White BC; Roberts JR; Edgerton M; Gonzalez A; Nadaf S; Moore JH; Caprioli RM; Carbone DP
    Lancet; 2003 Aug; 362(9382):433-9. PubMed ID: 12927430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.